ANAC 52W Low/High: 15.11 / 85.79 (now pre-mkt at 130.01)...so all is possible once corruption stops and things are back into normal via the law. With Red-it positive results, we might have a very similar pattern in terms of stock price. Long Term is the keyword
Yahoo stats can't be right - shows > 100% ownership and zero retail owners:
% of Shares Held by All Insider and 5% Owners: 21% % of Shares Held by Institutional & Mutual Fund Owners: 81% % of Float Held by Institutional & Mutual Fund Owners: 102% Number of Institutions Holding Shares: 112
$140/shr for a skin cream? Is that a joke? Anywho, BB's get a shout out from Insidermonkey - hopefully we will joint the ranks of their winners sooner rather than later! Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock’s closing price of $84.61 on Friday after the firm revealed that its Crisaborole ointment has succeeded in late-stage studies. The ointment treats atopic dermatitis in children as well as adults, a condition the National Institutes of Health says affects 9% to 30% of people in the U.S., making the potential market for the drug very large. Furthermore, Crisaborole is also being tested by the firm to treat proriasis. Year-to-date, the stock has surged by 171.62% and in the past 12 months, its ascent has been an even more impressive 388.23%. The stock is still up by over 40% in pre-market trading as of writing. The surge represents a strong start to the third quarter for Julian Baker and Felix Baker‘s Baker Bros. Advisors, which is coming off a second quarter in which it ranked as the top performing hedge fund in our database using our weighted average returns metric. Baker Bros. was the top shareholder of Anacor in our database as of March 31.
News 
Market Data 
Discover 
